Preclinical science is the first step in translational research. We assess biological mechanisms, safety, and therapeutic potential before clinical trials to ensure scientific confidence and reduce development risk.
Safety • Validation
A validation process – assessing safety and therapeutic potential before clinical trials.
Toxicology
PK/PD
Biomarker
Nutraceuticals
Comprehensive evaluation of toxicity and safety profiles in early-stage compounds and formulations to detect potential risks, strengthen biological safety understanding, and support progression toward clinical validation.
Toxicology Screening
Evaluation of pharmacokinetics and pharmacodynamics to understand how compounds interact with biological systems, including absorption, distribution, metabolism, and excretion, as well as their biological effects and dose-response relationships. This supports optimized dosing, efficacy insights, and clinical readiness.
PK/PD Analysis
Identification of biological indicators to support disease targeting, treatment monitoring, and clinical validation, enabling more precise understanding of biological responses and improved decision-making in translational research.
Biomarker Discovery
Scientific testing frameworks for supplements and functional ingredients to validate efficacy and biological relevance, supporting evidence-based development and reliable functional health claims.
Nutraceutical Validation Models
What is Novabiotech Asia?
Novabiotech Asia is a Malaysia-based Contract Research Organization (CRO) providing integrated translational life sciences services including preclinical research, clinical trial execution, diagnostic laboratory testing, biomarker discovery, and translational healthcare validation across Southeast Asia.
Industry
Contract Research Organization (CRO)
Location
Malaysia / Southeast Asia
Core Services
Preclinical, Clinical Trials, Diagnostics
Focus
Clinical Healthcare Innovation & Validation
Novabiotech Asia is a Malaysia-based Contract Research Organization (CRO) specializing in translational life sciences, clinical trials, diagnostics, and preclinical research.
We provide preclinical research, clinical trial execution (Phase I–III), diagnostic laboratory services, biomarker discovery, and translational healthcare validation.
Our clients include pharmaceutical companies, biotechnology firms, medical device manufacturers, hospitals, universities, and research institutions.
We are based in Malaysia and serve clients across Southeast Asia including Singapore, Thailand, Indonesia, and Vietnam.
Strong preclinical validation improves clinical success rates by ensuring only scientifically robust candidates advance into human trials, leading to reduced risk, stronger regulatory readiness, and better data quality.
This website uses cookies to improve your web experience.
